Related Experiment Video
Updated: Jul 8, 2026
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
09:58
Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
Published on: November 9, 2018
Future Directions for [18F]FDG PET in Central Nervous System Diseases
Eric Guedj1, Andrew B Newberg2, Abass Alavi3
1Aix Marseille University, APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Marseille, France.
PET Clinics
|July 6, 2026
Summary
Positron emission tomography (PET) using [18F]FDG is advancing with new computational methods and total-body imaging. These innovations promise more personalized brain dysfunction insights and systemic interactions for clinical use.
Area of Science:
- Neuroimaging
- Biomarker Development
- Radiochemistry
Background:
- [18F]FDG PET is a key molecular imaging technique for assessing brain metabolism.
- Current applications often rely on regional analysis, limiting detailed functional insights.
- Advancements in imaging technology and analytical methods are poised to enhance its utility.
Purpose of the Study:
- To explore the evolving landscape of [18F]FDG PET in neuroscience and clinical practice.
- To highlight new approaches for analyzing brain function and systemic interactions.
- To discuss the requirements for successful clinical integration of advanced [18F]FDG PET techniques.
Main Methods:
- Review of emerging trends in [18F]FDG PET data analysis, including network-based and computational approaches.
- Discussion of dynamic [18F]FDG PET and total-body PET for temporal and systemic analyses.
- Consideration of standardization and validation frameworks for multicenter studies.
Main Results:
- Network-based and computational methods offer more individualized descriptions of brain dysfunction.
- Dynamic and total-body PET enable the study of temporal physiology and brain-body interactions.
- Standardized, scalable frameworks are crucial for clinical translation and impact.
Conclusions:
- [18F]FDG PET is transitioning towards more sophisticated, individualized functional brain assessments.
- The integration of advanced analytical and imaging techniques positions [18F]FDG PET as a central functional biomarker.
- Successful clinical implementation hinges on robust, reproducible methodologies and clear interpretation guidelines.
Keywords:
Artificial intelligenceBrain metabolismFunctional PETMetabolic connectivityPrecision neurologyStandardizationTotal-body PET[18F]FDG PETMore Related Videos
Related Concept Videos
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET

![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)